The Cincinnati Enquirer reports:
Hatred of former President Donald Trump has kept researchers from looking into the anti-parasitic drug ivermectin and other drugs to treat COVID-19, Republican Kentucky Sen. Rand Paul told constituents on Friday.
“The hatred for Trump deranged these people so much, that they’re unwilling to objectively study it,” Paul said to the 60 people squeezed into the Cold Spring City Council chambers in this Northern Kentucky suburb just south of Cincinnati.
“So someone like me that’s in the middle on it, I can’t tell you because they will not study ivermectin. They will not study hydroxychloroquine without the taint of their hatred for Donald Trump.”
Read the full article. Paul went on to attack mask and vaccine mandates. He has refused to get vaccinated, claiming that he has immunity because he’s already had COVID. Rather obviously, there have been studies into ivermectin.
Rand Paul refuses to accept FDA and CDC warnings on ivermectin, is happy to endanger people’s lives to foster paranoia and weaken our country. https://t.co/sCsR8UJUqM
— Mark Jacob (@MarkJacob16) August 28, 2021
A reminder about Ivermectin, the anti-parasite pill that in Mississippi accounts for 70% of recent calls to its poison control centerhttps://t.co/DhdpLzLlqC
The main study supporting its use had to be withdrawn due to “plagiarism and data manipulation”https://t.co/X7wQE4O4AT pic.twitter.com/d8RNi3jQ1N— Eric Topol (@EricTopol) August 24, 2021
He was just trying to study COVID treatments. Ivermectin zealots sent hate mail calling him a Nazi. https://t.co/kQ2PUAALym
— Mother Jones (@MotherJones) August 25, 2021
A study earlier this year found that Ivermectin, a popular but unproven treatment for Covid-19, does not speed recovery in those who have a mild version of the disease. https://t.co/xLsTMppITe
— The New York Times (@nytimes) August 21, 2021
Column: Major study of Ivermectin, the anti-vaccine crowd’s latest COVID drug, finds ‘no effect whatsoever’ https://t.co/1MggR0e5uQ
— Michael Hiltzik (@hiltzikm) August 23, 2021